News
Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.
A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...
1don MSN
Aspirin halves the risk of recurrence in patients with colorectal cancer, clinical trial finds
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
A low dose reduces the likelihood of recurrence in people who have had surgery to remove tumors with a common genetic mutation, study finds.
News-Medical.Net on MSN
Low dose of aspirin cuts recurrence risk in colorectal cancer with genetic mutation
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized clinical trial that a low dose of the well-known medicine aspirin halves the risk ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
A groundbreaking new clinical trial has found that taking a low dose of the common fever medicine Aspirin halves the risk of ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
Newser on MSN
'Wonder Drug' Has Another Apparent Perk
A daily low dose of aspirin could sharply cut the risk of colorectal cancer returning after surgery, according to a large ...
A Swedish-led research team at Karolinska Institutet and Karolinska University Hospital has shown in a new randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback